#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Soft tissue necrosis Peripheral T-cell lymphoma unspecified Ovarian epithelial cancer Medulloblastoma recurrent Myeloproliferative neoplasm Glomerulonephritis membranous Dedifferentiated liposarcoma Neuroendocrine carcinoma of the skin Bronchopulmonary dysplasia Langerhans cell sarcoma Toxic epidermal necrolysis Optic glioma Alternating hemiplegia of childhood Neuroendocrine tumour of the lung Uveal melanoma More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis II Haemophagocytic lymphohistiocytosis – Life with Disease Haemophilia Activated PI3 kinase delta syndrome – Basic Information Anaplastic thyroid cancer – Diagnostics Andersen-Tawil syndrome Encephalitis autoimmune Synovial sarcoma metastatic Testicular leiomyosarcoma Angiosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ustekinumab BI-1607 SODIUM DIHYDROGEN PHOSPHATE Cd7-Cart01 Ibuprofen Arginine LUXDEGALUTAMIDE Tramadol Hydrochloride CARBOMER 980 Art0380 Mesilate Galunisertib Ferric Carboxymaltose PAPAVERINE HYDROCHLORIDE Germanium (68Ge) Chloride Histamine Dihydrochloride Egl-001 Zalunfiban Insulin Lispro Lovo-A Piperacillin Monohydrate Giredestrant More therapies…

    Learn about Your Condition

    Cutaneous T-cell lymphoma Myeloproliferative neoplasm Lymphocytic lymphoma Hepatobiliary cancer Abdominal wall pain Syphilis VEXAS syndrome Developmental hip dysplasia Rectosigmoid cancer Aortic stenosis Kearns-Sayre syndrome Cardiac failure Pituitary tumour benign Retinopathy proliferative Obstructive pancreatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Tuvusertib and Cemiplimab for Patients with Non-Squamous Non-Small Cell Lung Cancer After Previous Treatments

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • 2-Amino-6-Fluoro-N-(5-Fluoro-4-(1-Methyl-1H-Imidazol-5-Yl)Pyridin-3-Yl)Pyrazolo[1,5-A]Pyrimidine-3-Carboxamide
    • Cemiplimab
    Belgium France Germany Italy Spain

  • Study on Abemaciclib with Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer at Intermediate to High Risk

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer female
    • Human epidermal growth factor receptor negative
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Abemaciclib
    Germany Poland Spain

  • Study of Adagrasib Dosing in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Adagrasib
    Croatia France Greece Hungary Italy The Netherlands +3

  • Study on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Austria Belgium Czechia Denmark Finland France +7

  • Study of Tirzepatide and Placebo for People with Overweight or Obesity and Chronic Kidney Disease, with or without Type 2 Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    • Chronic kidney disease
    • Obesity
    Investigated Drugs:
    • Tirzepatide
    • Iohexol
    Austria Denmark The Netherlands

  • Study on the Effect of Famotidine in Reducing P-selectin Levels in Children with Sickle Cell Disease

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Famotidine
    France
Previous Page
1 … 1,641 1,642 1,643 1,644 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!